177 related articles for article (PubMed ID: 1266662)
21. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
Erkinaro T; Kavasmaa T; Ylikauma L; Mäkikallio K; Haapsamo M; Acharya G; Ohtonen P; Alahuhta S; Räsänen J
Reprod Sci; 2009 Aug; 16(8):749-57. PubMed ID: 19380903
[TBL] [Abstract][Full Text] [Related]
22. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
23. Haemodynamic effects of atenolol, pindolol and propranolol during adrenaline infusion in man.
Rehling M; Svendsen TL; Maltbaek N; Tangø M; Trap-Jensen J
Eur J Clin Pharmacol; 1986; 30(6):659-63. PubMed ID: 3533564
[TBL] [Abstract][Full Text] [Related]
24. Blood pressure and renin during treatment with pindolol.
Fyhrquist F; Kurppa K; Huuskonen M; Koistinen A
Acta Med Scand; 1977; 202(1-2):55-60. PubMed ID: 899884
[TBL] [Abstract][Full Text] [Related]
25. Effect of pindolol and nifedipine alone and in combination on haemodynamic parameters/variables in essential hypertension.
Tsukiyama H; Otsuka K; Yamamoto Y
J Int Med Res; 1984; 12(3):154-62. PubMed ID: 6734917
[TBL] [Abstract][Full Text] [Related]
26. Effects of diltiazem on hormonal and hemodynamic responses to lower body negative pressure and tilt in patients with mild to moderate systemic hypertension.
Mohanty PK; Sowers JR; McNamara C; Welch B; Beck F; Thames MD
Am J Cardiol; 1985 Dec; 56(16):28H-33H. PubMed ID: 3907320
[TBL] [Abstract][Full Text] [Related]
27. [Hemodynamic evaluation of pindolol].
Biffani G; Santini M
Minerva Cardioangiol; 1976 Sep; 24(9):613-8. PubMed ID: 1012501
[No Abstract] [Full Text] [Related]
28. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
Boneli J
Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
[No Abstract] [Full Text] [Related]
29. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
[TBL] [Abstract][Full Text] [Related]
30. [Proceedings: The effect of beta receptor treatment with pindolol on the plasma renin activity and the left-ventricular dynamics in essential hypertension].
Nussberger J; Vetter W; Krayenbühl HP; Siegenthaler
Schweiz Med Wochenschr; 1975 Nov; 105(44):1462-4. PubMed ID: 1215927
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Gibson DG
Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
[No Abstract] [Full Text] [Related]
32. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
[TBL] [Abstract][Full Text] [Related]
33. Acute haemodynamic effect of metoprolol in essential hypertension.
Pechán J; Mikulecký M; Srbecký M
Cor Vasa; 1988; 30(1):51-9. PubMed ID: 3132353
[TBL] [Abstract][Full Text] [Related]
34. Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics.
Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():425s-427s. PubMed ID: 7318347
[TBL] [Abstract][Full Text] [Related]
35. Pressor responsiveness, hemodynamics and plasma renin activity in essential hypertension.
Ishii M; Ono K; Ikeda T; Iizuka M; Nakamura Y
Jpn Circ J; 1974 Dec; 38(12):1078-84. PubMed ID: 4373593
[No Abstract] [Full Text] [Related]
36. Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
Levenson J; Simon AC; Moyse D; Bouthier J; Safar ME
Am Heart J; 1984 Oct; 108(4 Pt 2):1177-82. PubMed ID: 6148882
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic and humoral effects of chronic antihypertensive treatment with fenquizone: importance of aldosterone response.
Costa FV; Borghi C; Boschi S; Mussi A; Ambrosioni E
J Clin Pharmacol; 1990 Mar; 30(3):254-61. PubMed ID: 2179289
[TBL] [Abstract][Full Text] [Related]
38. Comparative clinical and hemodynamic investigations on two beta-receptor blocking agents (pindolol and mepindolol) in normal subjects.
Wink K
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):126-30. PubMed ID: 6715080
[TBL] [Abstract][Full Text] [Related]
39. The effect of pindolol on plasma renin activity in patients with essential hypertension.
Tényi I; Németh M; Jávor T; Nemes J; Czimer J
Eur J Clin Invest; 1977 Oct; 7(5):325-9. PubMed ID: 411662
[TBL] [Abstract][Full Text] [Related]
40. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
Mookherjee S; Obeid A; Warner R; Anderson G; Eich R; Smulyan H
Am J Cardiol; 1978 Dec; 42(6):987-92. PubMed ID: 727149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
